Effect of ANKASCIN 568-P Products Regulating Blood Lipid

Status Not yet recruiting

Clinical Trial Summary

This study is a randomized, double-blind, placebo-controlled, parallel-controlled trial (24 weeks in total), divided into three periods (screening, treatment, and discontinuation follow-up)

Clinical Trial Description

This experiment hopes to understand the effect of long-term consumption of red yeast rice products on blood lipid regulation and high-density lipoprotein cholesterol (HDL-C) elevation and to monitor the changes in the subjects' overall health status. This case is a randomized, double-blind, placebo-controlled trial. It is expected to recruit 80 subjects and randomly assign them to 2 groups to take red yeast rice products or a placebo for 24 weeks. The test group takes one red yeast rice capsule (containing 220 mg ANKASCIN 568-P), the control group took a placebo capsule of similar appearance (containing an equal weight of maltodextrin) every day, and blood samples were collected at 0, 4, and 12, 24, weeks for biochemical analysis and recorded. Subjects' general body position measurement, blood pressure, blood lipids, blood sugar and other related changes, and monitoring of liver, kidney, and thyroid function. ;

Study Design

Related Conditions & MeSH terms

Hyperlipidemias

Clinical Trial Details

NCT number	NCT05737355
Study type	Interventional
Source	SunWay Biotech Co., LTD.
Contact	Sean Lin
Phone	02-27929568
Email	sean.lin@sunway.cc
Status	Not yet recruiting
Phase	N/A
Start date	April 1, 2023
Completion date	May 31, 2025

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03793985` - Compare the Pharmacokinetics and Safety of CKD-391 With Co-administration of D086 and D337	Phase 1
Recruiting	`NCT03947866` - Ezetimibe-Rosuvastatin Evaluation Study
Withdrawn	`NCT04922424` - Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men	Phase 1
Completed	`NCT04516291` - A Dose-Ranging Study With Vupanorsen (TRANSLATE-TIMI 70)	Phase 2
Completed	`NCT03632668` - Evaluating the Pharmacokinetic Interaction Between AD-2071 and AD-2072	Phase 1
Completed	`NCT04701775` - Effect of Different Probiotic Strains in Hypercholesterolemic Patients	N/A
Completed	`NCT03534661` - L-NMMA on GLP-2 Mediated Intestinal Lipoprotein Release	Phase 2/Phase 3
Completed	`NCT03422666` - Plasma Lipoprotein Response to Glucagon-like Peptide-2	Phase 2/Phase 3
Completed	`NCT00536796` - Percentage of Secondary Prevention Patients Treated to Their LDL-C Targets	N/A
Completed	`NCT03643705` - A Nurse-led Intervention to Extend the HIV Treatment Cascade for Cardiovascular Disease Prevention	N/A
Recruiting	`NCT04560296` - Community-based E-Health Program for Older Adults Living With Chronic Diseases	N/A
Terminated	`NCT04073134` - The CHORAL Flow Study	Phase 4
Recruiting	`NCT05103254` - Bempedoic Acid Pregnancy Surveillance Program
Not yet recruiting	`NCT05015348` - Effects of Omega-3 PUFA on Lipids, Inflammatory Factors and Body Composition in Patients With Hyperlipidemia	N/A
Active, not recruiting	`NCT05082350` - Nutritional Intervention With Black Garlic	N/A
Not yet recruiting	`NCT04398771` - To Evaluate Safety and Effectiveness of RovatitanTab.
Not yet recruiting	`NCT04064281` - The Healthy Cantonese Diet on Cardiometabolic Syndrome	N/A
Recruiting	`NCT06257641` - Impact of the Mediterranean Diet on Patients With Psoriasis	N/A
Completed	`NCT03690778` - The PK Characteristics of the Co-administration of Metformin SR and Rosuvastatin and JLP-1310 in Healthy Male Volunteers.	Phase 1
Completed	`NCT04354987` - Compare the Pharmacokinetics and Safety of CKD-391	Phase 1